TD-6450 MAD Study in HCV Infected Subjects

Summary

This proof of concept study is designed to evaluate the safety, tolerability, pharmacokinetics, and antiviral activity of TD-6450 in treatment naïve subjects with GT-1, GT-2 or GT-3 chronic HCV.

Timeline

Start

2014-05

Primary completion

2014-10

Completion

2014-11

Drugs

Indications